D-Penam Hospital Antibiotic Meropenem 500mg Dry Injection Sterile Vial represents pharmaceutical precision in critical care medicine. Each vial contains Meropenem IP equivalent to ...

D-Penam Hospital Antibiotic Meropenem 500mg Dry Injection Sterile Vial represents pharmaceutical precision in critical care medicine. Each vial contains Meropenem IP equivalent to 500mg anhydrous Meropenem, formulated as a sterile dry powder for injection. This broad-spectrum carbapenem antibiotic is manufactured under stringent aseptic conditions to ensure maximum therapeutic efficacy and patient safety. The dry formulation provides extended shelf life and maintains stability until reconstitution, making it ideal for hospital pharmacies and healthcare facilities that require reliable, ready-to-use antibiotic solutions. Each vial delivers consistent 500mg dosing, supported by sodium carbonate IP for optimal pH balance upon reconstitution with appropriate diluents.

This essential antibiotic serves multiple healthcare sectors with particular importance in hospital medicine, critical care units, and surgical specialties. Infectious disease departments rely on D-Penam for treating multidrug-resistant bacterial infections, while oncology and hematology units utilize it for managing neutropenic sepsis in immunocompromised patients. Surgical wards employ it for perioperative prophylaxis in high-risk procedures including abdominal surgeries, organ transplants, and complex orthopedic operations. Emergency departments depend on its rapid bactericidal action for life-threatening infections including septic shock, meningitis, and complicated intra-abdominal infections. The product meets stringent hospital requirements for proven efficacy against both Gram-positive and Gram-negative pathogens.

D-Penam delivers exceptional value through consistent quality, manufacturing reliability, and therapeutic effectiveness that healthcare providers trust. Its manufacturing process adheres to international pharmaceutical standards, ensuring batch-to-batch consistency that supports predictable treatment outcomes. This reliability translates to reduced treatment failures, shorter hospital stays, and better patient recovery rates, ultimately helping healthcare institutions maintain their standards of care. The product's precise 500mg dosage and sterile formulation minimize preparation errors and contamination risks, while its extended stability supports efficient inventory management in hospital pharmacies.

Key Features:
- Contains Meropenem IP equivalent to 500mg anhydrous Meropenem per sterile vial
- Manufactured under strict aseptic conditions for injection safety and purity
- Includes sodium carbonate IP for optimal pH balance upon reconstitution
- Dry powder formulation ensures extended shelf life and temperature stability
- Precisely calibrated 500mg dosage per vial for consistent therapeutic delivery

Benefits:
- Provides reliable broad-spectrum coverage for severe bacterial infections
- Sterile formulation minimizes contamination risks during preparation and administration
- Extended shelf life supports efficient hospital inventory management
- Consistent 500mg dosage ensures accurate dosing and treatment predictability
- Suitable for multiple administration routes including IV infusion in critical care settings